SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Digital Turbine, Inc. engages in mobile growth platform solutions for advertisers, publishers, carriers, and device original equipment manufacturers. It operates through the following segments: On Device Solutions and App Growth Platform. The On Device Solutions segment consists of products and services that simplify the discovery and delivery of mobile apps and content media for device end users. The App Growth Platform segment provides Advertising Solutions and Ad Monetization Solutions. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Digital Turbines volatile pullback and range-bound trading are driving discussion, with traders debating whether low-volume selling and options activity are weighing on shares or creating a buying opportunity ahead of earnings. Bullish investors point to improving growth and cash flow, while others remain concerned about dilution and the stocks weakness.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

The FDAs acceptance of Intellias lonvo-z application for priority review has focused attention on its potential to bring a one-time gene-editing treatment for hereditary angioedema toward commercialization. Bulls see the regulatory milestone and Phase 3 results as validation, while skeptics point to financing and launch risks and question why the shares have reacted modestly.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

T-Mobile is drawing attention after SpaceXs spectrum deal intensified fears that Starlink Mobile could eventually compete with established wireless carriers, contributing to a sharp telecom selloff. Traders disagree on whether the threat warrants repricing now or is being overblown given the time, spectrum and ground infrastructure needed to build a rival network.

The mission of the Worldcoin project is to build the world’s largest identity and financial network as a public utility, giving ownership to everyone. A key component of the Worldcoin project is the development of the foundational infrastructure that will be important for a world where AI plays an increasingly large role.  The Worldcoin system revolves around World ID, a privacy-preserving global identity network. World ID enables users to verify their humanness online while maintaining their privacy through zero-knowledge proofs.  Using World ID, individuals will be able to prove that they are a real, unique human to any platform that integrates with the protocol, including to web3 systems, social networking sites, and governmental programs. This will enable fair airdrops or token/NFT sales, provide protection against bots/sybil attacks on social media, and enable the fairer distribution of limited governmental resources. Furthermore, World ID can also enable global democratic processes and novel forms of governance (e.g., via quadratic voting), and it may eventually show a path to AI-funded UBI. The Worldcoin token (WLD), alongside World ID, will let users participate in governing the Worldcoin protocol.   To engage with the Worldcoin protocol, individuals must first download a first wallet app that supports the creation of a World ID. Users visit a physical imaging device called the Orb to get their World ID Orb-verified. Orbs are operated by a network of independent local businesses called Orb Operators. The Orb uses multispectral sensors to verify humanness and uniqueness to issue an Orb-verified World ID, with all images being promptly deleted on-device per default (absent explicit consent to Data Custody). All Orb-verified World IDs holders are entitled to claim recurring grants of free WLD tokens, subject to certain availability restrictions. The WLD token is designed as a utility token with governance properties.

Worldcoin

Worldcoins sharp rally is driving attention, with traders pointing to the Grayscale ETF filing and renewed interest in its proof-of-human identity use case amid growing AI-agent activity; some also cite Eightcos large WLD holdings as a source of institutional interest. Optimism about further gains and a potential short squeeze is tempered by skepticism over the tokens volatility and the fact that ETF approval remains uncertain.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is drawing attention amid a high-volume rally and anticipation of founder Patrick Soon-Shiongs scheduled fireside chat, where investors are looking for trial updates. Traders also connect the broader NIH cancer-vaccine push to the companys investigational vaccine work; hopes for a partnership or short squeeze remain speculative.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

LINKs volatile rebound and repeated tests of resistance have fueled breakout talk, with bulls accumulating on dips while bears warn the move could fade. Traders also debate whether Chainlinks institutional and tokenization adoption will translate into lasting value for the LINK token.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinias planned early exit from its Rockville headquarters and procedural extensions in its generic-patent litigation have fueled speculation that a sale or further settlements may be approaching, though neither is confirmed. Traders welcomed the share-price rebound but debated whether it reflects company-specific developments or broader biotech-sector strength, with some expecting the gains to fade.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS is drawing attention over weaker 2027 Medicare Advantage star ratings for Aetna, which traders say could reduce bonus payments and pressure future margins; the setback is being contrasted with Humanas improved ratings. Some traders are bearish on the business impact, while others view the selloff as an oversold reaction.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Discussion centers on Compounds institutional push, including its institutional market launch, leadership changes, and planned V4 development; bullish traders also cite COMPs capped supply and anticipate a breakout. Others remain skeptical, pointing to its past underperformance and uneven price action.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

Long-term Treasury yields near multi-decade highs, amid inflation concerns tied partly to oil and expectations of a restrictive Fed, are weighing on TLT. Traders are split between expecting more downside as yields stay elevated and betting on a rebound or short squeeze after auction-related relief in yields.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can Marsh Beat Q3 Earnings on Risk and Insurance Services Strength?

MRSH heads into Q3 earnings with forecasts for higher revenue and profit, supported by Risk and Insurance Services growth, while rising costs pose a challenge.

Can Willis Towers' Growth Momentum Continue Amid Soft Pricing?

WTW's 5% organic growth is supported by specialty offerings, strong retention and new business, despite softer insurance pricing.

Can Marsh's AI Strategy Offset Softer Insurance Pricing?

MRSH is leaning on AI, data and technology to support growth and margins as softer insurance pricing puts pressure on premium-linked revenues.

BRO Stock Declines 27.1% in a Year: What Should Investors Do Now?

Brown & Brown's fee growth, acquisitions and strong cash flow support expansion, while rising expenses and interest costs pressure margins.


WTW Stock Trading at a Discount to Industry at 14.73X: Time to Hold?

Willis Towers Watson's organic growth, AI investments and acquisitions support expansion, while softer insurance rates and competition pose risks.


The Zacks Analyst Blog Highlights Willis Towers Watson, Arthur J. Gallagher and Aon

WTW, AJG and AON are finding new growth drivers as insurance pricing fades, with organic growth fueled by volume, retention and share gains.

3 Insurance Brokerage Stocks Find New Growth Drivers as Rates Fade

Organic growth for brokerage stocks like WTW, AJG and AON remains resilient as softer insurance pricing shifts the focus to underlying business activity.

Aon's $17 Billion USI Deal: A Costly Bet on Middle-Market Growth

Aon's $17B USI acquisition expands its middle-market reach and specialty capabilities, but adds debt and puts execution under pressure.

Willis Towers Watson (WTW) Upgraded to Buy: Here's What You Should Know

Willis Towers Watson (WTW) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

AJG's Organic Growth Resilience Supports Long-Term Expansion

Arthur J. Gallagher's durable organic growth, margin expansion and AssuredPartners integration support its outlook as insurance pricing moderates.

Willis Towers Watson Plc engages in the provision of advisory, broking, and solutions services. It operates through the following segments: Health, Wealth, and Career (HCW), Risk and Broking (R&B), and Corporate and Other. The HCW segment provides an array of advice, broking, solutions, and technology for employee benefit plans, institutional investors, compensation and career programs, and the employee experience overall. The R&B segment focuses on a broad range of risk advice, insurance brokerage, and consulting services to clients globally, ranging from small businesses to multinational corporations. The company was founded in 1828 and is headquartered in London, the United Kingdom.

Willis Towers Watson Public Limited Co

Insurance ETFs Top Defensive Sector Chart In July As Investors Look To Pivot Slightly From Chips And AI

Equity

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

WTW News